Insider Transactions in Q3 2022 at Agilon Health, Inc. (AGL)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
10,792
-49.86%
|
$237,424
$22.98 P/Share
|
|
Sep 27
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,792
+33.27%
|
$43,168
$4.49 P/Share
|
|
Sep 26
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$118,712
$22.62 P/Share
|
|
Sep 26
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Sep 09
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$186,162
$23.08 P/Share
|
|
Sep 09
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Sep 08
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
13,490
-32.33%
|
$296,780
$22.79 P/Share
|
|
Sep 08
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,490
+35.66%
|
$53,960
$4.49 P/Share
|
|
Aug 24
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$107,920
$20.9 P/Share
|
|
Aug 24
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Aug 23
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$107,920
$20.49 P/Share
|
|
Aug 23
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|
|
Aug 11
2022
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,337,500
-5.51%
|
$272,100,000
$24.35 P/Share
|
|
Aug 10
2022
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,009
+50.0%
|
-
|
|
Aug 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$186,162
$23.96 P/Share
|
|
Aug 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Aug 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$210,444
$26.09 P/Share
|
|
Aug 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Jul 21
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
79,768
-22.28%
|
$2,153,736
$27.5 P/Share
|
|
Jul 21
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,768
+18.22%
|
$79,768
$1.0 P/Share
|
|
Jul 21
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
50,000
-39.69%
|
$1,350,000
$27.84 P/Share
|
|
Jul 21
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,676
+39.17%
|
$49,676
$1.0 P/Share
|
|
Jul 20
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
50,000
-36.45%
|
$1,300,000
$26.52 P/Share
|
|
Jul 18
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$210,444
$26.57 P/Share
|
|
Jul 18
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Jul 15
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-42.72%
|
$210,444
$26.25 P/Share
|
|
Jul 15
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+29.93%
|
$32,376
$4.49 P/Share
|
|
Jul 07
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
319,071
-53.42%
|
$7,976,775
$25.0 P/Share
|
|
Jul 07
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
319,071
+34.82%
|
$319,071
$1.0 P/Share
|
|
Jul 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
41,187
-43.55%
|
$906,114
$22.66 P/Share
|
|
Jul 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,187
+44.18%
|
$164,748
$4.49 P/Share
|
|
Jul 01
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-33.21%
|
$113,316
$21.88 P/Share
|
|
Jul 01
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+24.93%
|
$21,584
$4.49 P/Share
|